Search Results - "Carsten Stephan"

Refine Results
  1. 1

    Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data by Fendler, Annika, Stephan, Carsten, Ralla, Bernhard, Jung, Klaus

    “…Clinical and preclinical studies have provided conflicting data on the postulated beneficial effects of vitamin D in patients with prostate cancer. In this…”
    Get full text
    Journal Article
  2. 2

    Prostate-specific antigen and other serum and urine markers in prostate cancer by Stephan, Carsten, Ralla, Bernhard, Jung, Klaus

    Published in Biochimica et biophysica acta (01-08-2014)
    “…Prostate-specific antigen (PSA) is one of the most widely used tumor markers, and strongly correlates with the risk of harboring from prostate cancer (PCa)…”
    Get full text
    Journal Article
  3. 3

    The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer by Gevensleben, Heidrun, Dietrich, Dimo, Golletz, Carsten, Steiner, Susanne, Jung, Maria, Thiesler, Thore, Majores, Michael, Stein, Johannes, Uhl, Barbara, Müller, Stefan, Ellinger, Jörg, Stephan, Carsten, Jung, Klaus, Brossart, Peter, Kristiansen, Glen

    Published in Clinical cancer research (15-04-2016)
    “…Therapies targeting the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway promote anti-tumor immunity and have shown promising results in…”
    Get full text
    Journal Article
  4. 4

    Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples by JUNG, Monika, SCHAEFER, Annika, STEINER, Isabel, KEMPKENSTEFFEN, Carsten, STEPHAN, Carsten, ERBERSDOBLER, Andreas, JUNG, Klaus

    Published in Clinical chemistry (Baltimore, Md.) (01-06-2010)
    “…RNA integrity is the essential factor that determines the accuracy of mRNA transcript measurements obtained with quantitative real-time reverse-transcription…”
    Get full text
    Journal Article
  5. 5

    Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p by Wotschofsky, Zofia, Gummlich, Linda, Liep, Julia, Stephan, Carsten, Kilic, Ergin, Jung, Klaus, Billaud, Jean-Noel, Meyer, Hellmuth-Alexander

    Published in PloS one (09-02-2016)
    “…MicroRNAs (miRNAs) regulate gene expression by interfering translation or stability of target transcripts. This interplay between miRNA and their mRNA has been…”
    Get full text
    Journal Article
  6. 6

    Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer by Stephan, Carsten, Vincendeau, Sébastien, Houlgatte, Alain, Cammann, Henning, Jung, Klaus, Semjonow, Axel

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2013)
    “…Total prostate-specific antigen (tPSA) is flawed for prostate cancer (PCa) detection. [-2]proprostate-specific antigen (p2PSA), a molecular isoform of free PSA…”
    Get full text
    Journal Article
  7. 7

    Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma by Schaefer, Annika, Jung, Monika, Mollenkopf, Hans‐Joachim, Wagner, Ina, Stephan, Carsten, Jentzmik, Florian, Miller, Kurt, Lein, Michael, Kristiansen, Glen, Jung, Klaus

    Published in International journal of cancer (01-03-2010)
    “…This study aimed to investigate the microRNA (miRNA) profile in prostate carcinoma tissue by microarray analysis and RT‐qPCR, to clarify associations of miRNA…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine by Stephan, Carsten, Jung, Klaus

    “…Prostate cancer (PCa) is, with an estimated number of 161,360 cases and 26,730 deaths in 2017, the most common malignancy in the USA [...]…”
    Get full text
    Journal Article
  10. 10

    MicroRNAs as Regulators of Signal Transduction in Urological Tumors by FENDLER, Annika, STEPHAN, Carsten, YOUSEF, George M, JUNG, Klaus

    Published in Clinical chemistry (Baltimore, Md.) (01-07-2011)
    “…MicroRNAs (miRNAs) are short noncoding RNAs that have been shown to play pivotal roles in carcinogenesis. In the past decade, miRNAs have been the focus of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1 by Fendler, Annika, Jung, Monika, Stephan, Carsten, Erbersdobler, Andreas, Jung, Klaus, Yousef, George M

    Published in PloS one (19-11-2013)
    “…microRNAs (miRNAs) are small molecules that regulate gene expression posttranscriptionally. In a previous study, we identified miR-96 to be upregulated in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer by Fritzsche, Florian R, Weichert, Wilko, Röske, Annika, Gekeler, Volker, Beckers, Thomas, Stephan, Carsten, Jung, Klaus, Scholman, Katharina, Denkert, Carsten, Dietel, Manfred, Kristiansen, Glen

    Published in BMC cancer (19-12-2008)
    “…Enhanced activity of histone deacetylases (HDAC) is associated with more aggressive tumour behaviour and tumour progression in various solid tumours. The…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature by Zhao, Zhongwei, Weickmann, Sabine, Jung, Monika, Lein, Michael, Kilic, Ergin, Stephan, Carsten, Erbersdobler, Andreas, Fendler, Annika, Jung, Klaus

    Published in Cancers (21-10-2019)
    “…Within five to ten years after radical prostatectomy (RP), approximately 15–34% of prostate cancer (PCa) patients experience biochemical recurrence (BCR),…”
    Get full text
    Journal Article